Rational basis for the use of non-steroidal antiinflammatory drugs (and selective COX-2 inhibitors);Rationale verwendung nicht-steroidaler antiphlogistischer analgetika (inklusive selektiver COX-2-hemmer) in der praxis

Aktuelle Rheumatologie

Volumn 24, Issue 4, 1999, Pages 102-108

  Brune, K ^a   Hinz, B ^a   Zeilhofer, H U ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTANOID;

ANALGESIA; ARTICLE; BIOAVAILABILITY; DRUG ABSORPTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; ENZYME ANALYSIS; ENZYME INHIBITION; GASTROINTESTINAL TOXICITY; HUMAN; INFLAMMATION; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; THROMBOCYTE DYSFUNCTION;

EID: 0032876378     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043556     Document Type: Article

References (19)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol 1971; 231: 232-235
2. Patrignani P, Panara MR, Sciulli MG, Santini G, Renda G, Patrono C. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J Physiol Pharmacol 1997; 48: 623-631
3. Brune K. How aspirin might work: a pharmacokinetic approach. Agents Actions 1974; 4: 230-232
4. Rainsford KD, Schweitzer A, Brune K. Autoradiographic and biochemical observations on the distribution of non-steroid antiinflammatory drugs. Arch Int Pharmacodyn Ther 1981; 250: 180-194
5. Brune K, Rainsford KD, Schweitzer A. Biodistribution of mild analgesics. Br J Clin Pharmacol 1980, 10 (Suppl 2): 279-284
6. Brune K, Lanz R. Pharmacokinetics of non-steroidal anti-inflammatory drugs. In: Bonta IL, Bray MA, Parnham MJ (eds.). Handbook of inflammation, Vol. 5, The Pharmacology of Inflammation 1985: pp 413-449
7. Masferrer JL, Zweifel BS, Seibert S, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990; 86: 1375-1379
8. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990; 265: 16737-16740
9. Hinz B, Brune K. Spezifische COX-2-Inhibitoren: Perspektiven einer Therapie mit neuen analgetischen und antiinflammatorischen Wirkstoffen. Wien Klin Wochenschr 1999; 111: 103-112
10. Brune K, Zeilhofer HU, Hinz B. Cyclo-oxygenase inhibitors: new insights. In: Emery P (ed.). Rheumatology Highlights 1998-99. Oxford: Health press, (1999) pp. 18-24
11. Lanza FL, Rack MF, Simon TJ, Quan H, Bolognese JA, Hoover ME, Wilson FR, Harper SE. Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Aliment Pharmacol Ther 1999; 13: 761-767
12. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997; 112: 387-397
13. Schmassmann A, Peskar BM, Stettler C, Netzer P, Stroff T, Flogerzi B, Halter F. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 1998; 123: 795-804
14. Tocco G, Freire-Moar J, Schreiber SS, Sakhi SH, Aisen PS, Pasinetti GM. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp Neurol 1997; 144: 339-349
15. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409-412
16. Parrett ML, Harris RE, Joarder FS, Ross MS, Clausen KP, Robertson FM. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 1997; 10: 503-507
17. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997, 57: 1276-1280
18. Brune K. Optimierte Diclofenac-Therapie mit Hilfe galenischer Innovationen. In: Venbrocks R, Salis-Soglio G (Hrsg.). Jahrbuch der Orthopädie 1995. Zülpich: Biermann-Verlag, 1995: 235-241
19. Andrade SE, Martinez C, Walker AM. Comparative Safety Evaluation of Non-narcotic Analgesis. J Clin Epidemiol 1998; 51: 1357-1365